Axil Brands vs Cbdmd
Axil Brands is the larger business, with $30.8m of revenue in fiscal 2026 against $19.2m for Cbdmd (1.6 times as much). Axil Brands grew faster (17.5% against -1.5%). Axil Brands kept more of each dollar of sales as profit: a net margin of 8.8% against -10.6%.
| Latest fiscal year | Axil BrandsAXIL, 2026 | CbdmdYCBD, 2025 |
|---|---|---|
| Revenue | $30.8m | $19.2m |
| Revenue growth | 17.5% | -1.5% |
| Net income | $2.7m | −$2.0m |
| Operating margin | 9.7% | — |
| Net margin | 8.8% | -10.6% |
| Return on equity | 23.7% | -44.4% |
| Free cash flow | −$89,020 | −$1.6m |
| Cash | $4.5m | $2.3m |
| Total debt | $142,864 | $0 |
| Debt to equity | 1.1% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $39.4m | $4.7m |
| Price vs our value range | Above our value range | — |
| Moat score | 36 (Weak) | 30 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 3 sales |